Literature DB >> 32216281

Oxyaapa: A Picolinate-Based Ligand with Five Oxygen Donors that Strongly Chelates Lanthanides.

Aohan Hu1, Ivan Keresztes1, Samantha N MacMillan1, Yang Yang1, Erdong Ding1, Warren R Zipfel2, Robert A DiStasio1, John W Babich3, Justin J Wilson1.   

Abstract

Coordination compounds of the lanthanide ions (Ln3+) have important applications in medicine due to their photophysical, magnetic, and nuclear properties. To effectively use the Ln3+ ions for these applications, chelators that stably bind them in vivo are required to prevent toxic side effects that arise from localization of these ions in off-target tissue. In this study, two new picolinate-containing chelators, a heptadentate ligand OxyMepa and a nonadentate ligand Oxyaapa, were prepared, and their coordination chemistries with Ln3+ ions were thoroughly investigated to evaluate their suitability for use in medicine. Protonation constants of these chelators and stability constants for their Ln3+ complexes were evaluated. Both ligands exhibit a thermodynamic preference for small Ln3+ ions. The log KLuL = 12.21 and 21.49 for OxyMepa and Oxyaapa, respectively, indicating that the nonadentate Oxyaapa forms complexes of significantly higher stability than the heptadentate OxyMepa. X-ray crystal structures of the Lu3+ complexes were obtained, revealing that Oxyaapa saturates the coordination sphere of Lu3+, whereas OxyMepa leaves an additional open coordination site for a bound water ligand. Solution structural studies carried out with NMR spectroscopy revealed the presence of two possible conformations for these ligands upon Ln3+ binding. Density functional theory (DFT) calculations were applied to probe the geometries and energies of these conformations. Energy differences obtained by DFT are small but consistent with experimental data. The photophysical properties of the Eu3+ and Tb3+ complexes were characterized, revealing modest photoluminescent quantum yields of <2%. Luminescence lifetime measurements were carried out in H2O and D2O, showing that the Eu3+ and Tb3+ complexes of OxyMepa have two inner-sphere water ligands, whereas the Eu3+ and Tb3+ complexes of Oxyaapa have zero. Lastly, variable-temperature 17O NMR spectroscopy was performed for the Gd-OxyMepa complex to determine its water exchange rate constant of kex298 = (2.8 ± 0.1) × 106 s-1. Collectively, this comprehensive characterization of these Ln3+ chelators provides valuable insight for their potential use in medicine and garners additional understanding of ligand design strategies.

Entities:  

Year:  2020        PMID: 32216281      PMCID: PMC8111572          DOI: 10.1021/acs.inorgchem.0c00372

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  54 in total

1.  Reevaluation of absolute luminescence quantum yields of standard solutions using a spectrometer with an integrating sphere and a back-thinned CCD detector.

Authors:  Kengo Suzuki; Atsushi Kobayashi; Shigeo Kaneko; Kazuyuki Takehira; Toshitada Yoshihara; Hitoshi Ishida; Yoshimi Shiina; Shigero Oishi; Seiji Tobita
Journal:  Phys Chem Chem Phys       Date:  2009-09-17       Impact factor: 3.676

2.  Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands.

Authors:  J B Stimmel; F C Kull
Journal:  Nucl Med Biol       Date:  1998-02       Impact factor: 2.408

3.  H4octapa: highly stable complexation of lanthanide(III) ions and copper(II).

Authors:  Ferenc Krisztián Kálmán; Andrea Végh; Martín Regueiro-Figueroa; Éva Tóth; Carlos Platas-Iglesias; Gyula Tircsó
Journal:  Inorg Chem       Date:  2015-02-18       Impact factor: 5.165

4.  H4octapa: an acyclic chelator for 111In radiopharmaceuticals.

Authors:  Eric W Price; Jacqueline F Cawthray; Gwendolyn A Bailey; Cara L Ferreira; Eszter Boros; Michael J Adam; Chris Orvig
Journal:  J Am Chem Soc       Date:  2012-05-11       Impact factor: 15.419

Review 5.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

6.  H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions.

Authors:  María de Guadalupe Jaraquemada-Peláez; Xiaozhu Wang; Thomas J Clough; Yang Cao; Neha Choudhary; Kirsten Emler; Brian O Patrick; Chris Orvig
Journal:  Dalton Trans       Date:  2017-10-31       Impact factor: 4.390

7.  Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine Applications.

Authors:  Eduardo Aluicio-Sarduy; Nikki A Thiele; Kirsten E Martin; Brett A Vaughn; Justin Devaraj; Aeli P Olson; Todd E Barnhart; Justin J Wilson; Eszter Boros; Jonathan W Engle
Journal:  Chemistry       Date:  2020-01-09       Impact factor: 5.236

8.  H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.

Authors:  Eric W Price; Brian M Zeglis; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Dalton Trans       Date:  2014-01-07       Impact factor: 4.390

9.  H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.

Authors:  Gwendolyn A Bailey; Eric W Price; Brian M Zeglis; Cara L Ferreira; Eszter Boros; Michael J Lacasse; Brian O Patrick; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Inorg Chem       Date:  2012-10-29       Impact factor: 5.165

Review 10.  The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.

Authors:  Graeme J Stasiuk; Nicholas J Long
Journal:  Chem Commun (Camb)       Date:  2013-04-07       Impact factor: 6.222

View more
  5 in total

1.  Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications.

Authors:  Aohan Hu; Justin J Wilson
Journal:  Acc Chem Res       Date:  2022-03-01       Impact factor: 24.466

2.  Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for 230U Targeted α-Therapy.

Authors:  Joshua J Woods; Ryan Unnerstall; Abbie Hasson; Diane S Abou; Valery Radchenko; Daniel L J Thorek; Justin J Wilson
Journal:  Inorg Chem       Date:  2022-02-09       Impact factor: 5.436

3.  Chelating the Alpha Therapy Radionuclides 225Ac3+ and 213Bi3+ with 18-Membered Macrocyclic Ligands Macrodipa and Py-Macrodipa.

Authors:  Aohan Hu; Victoria Brown; Samantha N MacMillan; Valery Radchenko; Hua Yang; Luke Wharton; Caterina F Ramogida; Justin J Wilson
Journal:  Inorg Chem       Date:  2021-12-29       Impact factor: 5.436

4.  Toward Bifunctional Chelators for Thallium-201 for Use in Nuclear Medicine.

Authors:  Alex Rigby; George Firth; Charlotte Rivas; Truc Pham; Jana Kim; Andreas Phanopoulos; Luke Wharton; Aidan Ingham; Lily Li; Michelle T Ma; Chris Orvig; Philip J Blower; Samantha Y A Terry; Vincenzo Abbate
Journal:  Bioconjug Chem       Date:  2022-07-08       Impact factor: 6.069

5.  Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.

Authors:  Aohan Hu; Eduardo Aluicio-Sarduy; Victoria Brown; Samantha N MacMillan; Kaelyn V Becker; Todd E Barnhart; Valery Radchenko; Caterina F Ramogida; Jonathan W Engle; Justin J Wilson
Journal:  J Am Chem Soc       Date:  2021-06-30       Impact factor: 16.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.